Literature DB >> 18786484

Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.

Andrew Sharp1, Robyn Tapp, Darrel P Francis, Simon A McG Thom, Alun D Hughes, Alice V Stanton, Andrew Zambanini, Nish Chaturvedi, Sheila Byrd, Neil R Poulter, Peter S Sever, Jamil Mayet.   

Abstract

OBJECTIVES: We investigated whether diastolic function differs between hypertensive patients of African-Caribbean or white European origin and established whether differences could be explained by confounding variables.
BACKGROUND: African Caribbeans are known to have a higher prevalence of heart failure than white Europeans but it is unclear whether this is a result of known risk factors. Tissue Doppler technology now allows accurate quantification of diastolic function, which is recognized as an important factor in the development of heart failure.
METHODS: Participants from a single center participating in the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial), composed of patients with hypertension but no evidence of heart failure, were studied. Left ventricular structure and function were measured in 509 patients using conventional and tissue Doppler echocardiography. Diastolic function was assessed using the tissue Doppler early diastolic velocity E' (averaged from 3 left ventricular segments) and the ratio of this and the transmitral early filling velocity E (E/E').
RESULTS: In African-Caribbean patients, mean E' was significantly lower (7.7 cm/s vs. 8.6 cm/s, p = 0.003) and mean E/E' was significantly higher (8.85 vs. 7.93, p = 0.003). After adjustment for confounding variables-age, gender, systolic blood pressure, pulse pressure, cholesterol, smoking, ejection fraction, left ventricular mass index, and diabetes mellitus-the effect of African-Caribbean ethnicity on diastolic function remained highly significant (E': 7.52 vs. 8.51; p < 0.001; E/E': 8.89 vs. 7.93; p = 0.003; African Caribbeans vs. white Europeans for both comparisons).
CONCLUSIONS: Diastolic function is significantly worse in hypertensive patients of African-Caribbean origin than in white Europeans. This difference in diastolic performance is not due to known confounding variables.

Entities:  

Mesh:

Year:  2008        PMID: 18786484     DOI: 10.1016/j.jacc.2008.04.065

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Race/ethnic disparities in left ventricular diastolic function in a triethnic community cohort.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

Review 2.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

Review 3.  Preventing Heart Failure by Treating Systolic Hypertension: What Does the SPRINT Add?

Authors:  Bharathi Upadhya; Richard B Stacey; Dalane W Kitzman
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

4.  [Heart failure with preserved left ventricular ejection fraction].

Authors:  Johannes Petutschnigg; Frank Edelmann
Journal:  Internist (Berl)       Date:  2019-09       Impact factor: 0.743

5.  Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.

Authors:  Alvin Chandra; Hicham Skali; Brian Claggett; Scott D Solomon; Joseph S Rossi; Stuart D Russell; Kunihiro Matsushita; Dalane W Kitzman; Suma H Konety; Thomas H Mosley; Patricia P Chang; Amil M Shah
Journal:  J Am Coll Cardiol       Date:  2022-02-01       Impact factor: 24.094

Review 6.  Ventricular remodeling in heart failure with preserved ejection fraction.

Authors:  Amil M Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 7.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Abhinav Dhingra; Aayushi Garg; Simrat Kaur; Saurav Chopra; Jaspreet Singh Batra; Ambarish Pandey; Antoine H Chaanine; Sunil K Agarwal
Journal:  Curr Heart Fail Rep       Date:  2014-12

8.  Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Authors:  Richard E Katholi; Daniel M Couri
Journal:  Int J Hypertens       Date:  2011-06-30       Impact factor: 2.420

9.  Genetically determined pattern of left ventricular function in normal and hypertensive hearts.

Authors:  Attila Kovács; Andrea Ágnes Molnár; Márton Kolossváry; Bálint Szilveszter; Alexisz Panajotu; Bálint Károly Lakatos; Levente Littvay; Ádám Domonkos Tárnoki; Dávid László Tárnoki; Szilard Voros; György Jermendy; Partho P Sengupta; Béla Merkely; Pál Maurovich-Horvat
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-09       Impact factor: 3.738

10.  The association of hypertension, hypertension duration, and control with incident heart failure in black and white adults.

Authors:  Matthew T Mefford; Parag Goyal; George Howard; Raegan W Durant; Nancy E Dunlap; Monika M Safford; Paul Muntner; Emily B Levitan
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.